HYDROCHLOROTHIAZIDE; METHYLDOPA - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydrochlorothiazide; methyldopa and what is the scope of freedom to operate?
Hydrochlorothiazide; methyldopa
is the generic ingredient in five branded drugs marketed by Merck, Chartwell Rx, Dava Pharms Inc, Ivax Sub Teva Pharms, Parke Davis, Purepac Pharm, Rising, Sandoz, Strides Pharma, Teva, and Watson Labs, and is included in forty-four NDAs. Additional information is available in the individual branded drug profile pages.Summary for HYDROCHLOROTHIAZIDE; METHYLDOPA
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 11 |
| NDAs: | 44 |
| DailyMed Link: | HYDROCHLOROTHIAZIDE; METHYLDOPA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCHLOROTHIAZIDE; METHYLDOPA
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; METHYLDOPA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | METHYLDOPA AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; methyldopa | TABLET;ORAL | 070829-001 | Mar 9, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | METHYLDOPA AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; methyldopa | TABLET;ORAL | 071900-001 | Nov 23, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | METHYLDOPA AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; methyldopa | TABLET;ORAL | 070960-001 | Feb 6, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | METHYLDOPA AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; methyldopa | TABLET;ORAL | 070543-001 | Jan 15, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
